Latest news with #AnupamRasayan
United News of India
a day ago
- Business
- United News of India
Anupam Rasayan India Ltd signs MPA with a Japanese Multinational Conglomerate
Mumbai, Jun 12 (UNI)Anupam Rasayan India Ltd on Thursday said that it has signed a long-term Master Purchase Agreement (MPA) with a Japan-based Multinational Conglomerate., a global leader in fluorochemicals and advanced technology solutions. This long-term partnership underscores MNC's confidence in Anupam's expertise and positions Anupam as a key supplier in high-growth market segments. The agreement establishes comprehensive terms governing the customer's purchase of specialty chemicals from Anupam Rasayan, marking a significant milestone in Anupam's strategic expansion into the Japanese market. Anand Desai, Managing Director of Anupam Rasayan, emphasized his confidence, stating, 'Partnering with a global leader speaks to the strength of Anupam's R&D, our commitment to innovative chemistry, and our ability to deliver at scale. This agreement brings both immediate and long-term commercial value, representing a major step in our growth journey. UNI JS BD
&w=3840&q=100)
Business Standard
2 days ago
- Automotive
- Business Standard
Here's why Anupam Rasayan shares hit 52-week high today; details inside
Anupam Rasayan share price: Chemical manufacturing company Anupam Rasayan share price was in demand on Thursday, June 12, 2025, with the stock rallying up to 4.36 per cent to hit a fresh 52-week high of ₹1,151 per share. However, by 12:50 PM, shares of Anupam Rasayan were off highs, and were trading merely 0.20 per cent higher at ₹1,105.10 per share. Follow Latest Stock Market Updates Today LIVE What triggered the rally in Anupam Rasayan shares today? Anupam Rasayan shares surged today following a series of strategic developments that boosted investor sentiment. The company signed a Letter of Intent (LOI) with two major European players—E-Lyte Innovations GmbH, a developer of electrolyte solutions, and FUCHS LUBRICANTS GERMANY GmbH, a subsidiary of FUCHS SE known for advanced lubricant technologies. This marks Anupam Rasayan's entry into the fast-growing lithium-ion battery chemicals market. Anand Desai, managing director of Anupam Rasayan, said, 'This partnership with E-Lyte and FUCHS LUBRICANTS GERMANY is a significant step forward in our planned journey of diversification and growth into the energy storage segment. This LOI is a crucial step towards establishing a long-term relationship and a strategic partnership with E-Lyte and FUCHS LUBRICANTS GERMANY for supply of high-quality cost-effective electrolyte salts. Under the LOI, Anupam Rasayan will supply up to 1,500 tonnes per annum (TPA) of Lithium Hexafluorophosphate (LiPF6), a critical component in battery manufacturing, with commercial deliveries expected as early as FY26–27. The LOI sets the groundwork for negotiating a five-year supply contract. E-Lyte is a leading innovator in the battery sector, specialising in advanced liquid electrolytes for next-generation energy storage systems, particularly in e-mobility applications. Since 2022, FUCHS LUBRICANTS GERMANY GmbH has supported E-Lyte as a minority shareholder and strategic partner, helping drive its expansion to meet rising global demand. ALSO READ | Desai added, 'Our process optimisation capabilities have played a pivotal role in ensuring the product's validation, offering significant advantages over its global commercial scenario. Additionally, our backward integration in fluorine chemistry through our subsidiary, Tanfac Industries Ltd, provides raw material supply chain security— a critical factor that contributed to signing this LOI. Anupam will be one of the first manufacturers of this molecule in India commercially, strengthening our foothold in the rapidly expanding battery ecosystem. Entering the battery chemicals market positions Anupam as a preferred partner for global innovators in advanced energy solutions. This is one of the many products Anupam is working on in the battery space that has been successfully agreed for supply to a customer, with several others in the pipeline.' In a separate development the company announced a long-term Master Purchase Agreement (MPA) with a Japan-based multinational conglomerate—a global leader in fluorochemicals and advanced technologies. This agreement solidifies Anupam's role as a key supplier in high-growth specialty chemical segments and expands its footprint in the Japanese market. About Anupam Rasayan Anupam Rasayan India Ltd. is among the leading Indian specialty chemicals companies, established in 1984, with a strong focus on custom synthesis and manufacturing. The company operates across two main verticals, Life Science Specialty Chemicals—including products for agrochemicals, personal care, and pharmaceuticals—and Other Specialty Chemicals, which cover pigments, dyes, and polymer additives. Serving over 71 domestic and international clients, including 31 multinational corporations, Anupam Rasayan has built a diversified customer base. It operates six manufacturing facilities in Gujarat—four in Sachin, Surat and two in Jhagadia, Bharuch—with a combined installed capacity of approximately 30,000 MT as of March 31, 2025. Known for its expertise in multistep synthesis and complex chemical processes, the company plays a key role in supplying high-value specialty chemicals to both Indian and global markets.
Business Standard
2 days ago
- Automotive
- Business Standard
Anupam Rasayan signs LoI with E-Lyte and Fuchs Lubricants Germany
For long term supply of high-quality cost-effective electrolyte salts Anupam Rasayan India has signed a Letter of Intent (LOI) with E-Lyte Innovations GmbH (E-Lyte) a European developer and supplier of electrolyte solutions for energy storage and FUCHS LUBRICANTS GERMANY GmbH. a subsidiary of FUCHS SE working on innovative lubricant solutions. This LOI is considered the entry point for Anupam Rasayan's collaboration with leading European companies within the battery value chain to take the next step in entering the fast-growing lithium-ion battery chemicals market. This agreement now lays the foundation of negotiating a supply contract with an initial term of five years. Commercial deliveries could begin as early as FY 2026-2027. The LOI envisions supply of a volume of up to 1,500 TPA of Lithium Hexafluorophosphate (LiPF6), based on market conditions. The LOI is subject to standard terms as regards generally accepted rights for an agreement of this nature. E-Lyte is at the forefront of innovation in the battery sector, developing and producing breakthrough liquid electrolytes for innovative energy storage systems used in various applications, with a focus on e-mobility. Since 2022, FUCHS LUBRICANTS GERMANY GmbH has been supporting E-Lyte in its role as minority shareholder and strategic partner in expansion to meet the steadily growing demand.
Business Standard
26-05-2025
- Business
- Business Standard
Anupam Rasayan rises after Q4 PAT climbs 44% YoY to Rs 45 cr
Anupam Rasayan India rose 2.41% to Rs 687.60 after the company's consolidated net profit surged 44.19% to Rs 44.57 crore on a 24.72% jump in revenue from operations to Rs 500.16 crore in Q4 FY25 over Q4 FY24. Profit before tax stood at Rs 88.12 crore in Q4 FY25, registering the growth of 52.16%, compared with Rs 57.91 crore posted in the corresponding quarter last year. EBITDA (including other income) was at Rs 150 crore in Q4 FY25 as compared to Rs 104.7 crore in Q4 FY24, up 43%, and this would translate into 30% EBITDA margin in this quarter. Total expenses rose 17.58% year on year to Rs 417.58 crore during the quarter. cost of materials consumed stood at Rs 282.97 crore (up 119.61% YoY), while employee benefits expense was at Rs 18.41 crore (up 8.35% YoY) during the period under review. On a full-year basis, the company's consolidated net profit fell 27.41% to Rs 93.35 crore on 2.58% decrease in revenue to Rs 1,436.97 crore in FY25 over FY24. Anand Desai, managing director of Anupam Rasayan, commented, Consolidated revenue for the quarter Q4 FY25 stood at Rs 506 crore registering a growth of 22% YoY and 31% QoQ. Consolidated revenue for the full year FY25 stood at Rs 1,448 crore registering a degrowth of 4% YoY. This performance was supported by growth in pharma and polymer coupled with strong performance from Tanfac. Margins have remained consistent this quarter, reflecting our focus on operational efficiency and a favorable product mix. While H1 FY25 was subdued due to weak macro conditions, I am pleased to share that H2 has shown clear signs of recovery particularly in Q4 FY25 where we have seen meaningful improvement with sales increasing both yearon-year and sequentially. We remain confident in our ability to return to the historical growth rates achieved prior to the recent slowdown. Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Its business verticals are life science-related specialty chemicals, comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising specialty pigments and dyes and polymer additives.
Yahoo
26-05-2025
- Business
- Yahoo
Anupam Rasayan India Ltd (BOM:543275) Q4 2025 Earnings Call Highlights: Strong Revenue Growth ...
Release Date: May 24, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Anupam Rasayan India Ltd (BOM:543275) reported a 22% year-over-year revenue growth for Q4 FY25, indicating a positive turnaround in performance. The company successfully launched nine new molecules across various segments, including pharma, agro, and polymer, which are expected to drive future growth. Strong performance in the pharma and polymer segments contributed significantly to the company's top line, aligning with their strategy to diversify the revenue base. The company has a robust order book of INR 14,646 crores, with a significant portion expected to be commercialized in FY26, providing a strong revenue pipeline. Anupam Rasayan India Ltd (BOM:543275) is seeing strong traction in the US market, with recent contracts expected to contribute meaningfully to sales in FY26. The company's full-year revenue for FY25 declined by 4% year-over-year, indicating challenges in maintaining consistent growth. Working capital remains a challenge due to a recent slowdown in sales, with a focus on improving working capital intensity moving forward. Despite the positive Q4 performance, the first half of FY25 was subdued due to weak market conditions, impacting overall annual results. The company faces high inventory levels and receivables, which are expected to reduce over the course of the year but currently pose a financial strain. There is a need for additional CapEx to support the ramp-up of new products, particularly in the battery chemicals segment, which could impact short-term financials. Warning! GuruFocus has detected 9 Warning Signs with BOM:543275. Q: What has led to the significant growth in the Agrobusiness vertical, and can we expect similar growth in FY26? A: The growth in the Agrobusiness vertical is attributed to the ramp-up of a high-value critical molecule, which was part of an LOI signed in 2022. This molecule has a large market size, and the company expects it to contribute significantly to revenue in FY26 and beyond. (Respondent: Unidentified_6) Q: Can you provide more details on the LOI with Elementum Materials for EV battery chemicals, and what is the expected CapEx? A: The LOI with Elementum Materials involves supplying high-end electrolytes for lithium-ion batteries. The initial volumes will be supplied from existing facilities, but significant ramp-up is expected post-FY26, which may require additional CapEx. The company is currently sizing the plant capacities and will share details once finalized. (Respondent: Unidentified_6) Q: Is there competition for the battery chemicals product from China, and how does Anupam Rasayan stand out? A: The product is patented and developed by Elementum, providing strong IP protection. Additionally, there is a global shift in supply chain sourcing, favoring countries like India. Anupam Rasayan's vertical integration and acquisition of 10 pack give it a strong edge in this product. (Respondent: Unidentified_6) Q: What is the expected revenue contribution from the LOIs that will commercialize in CY25-FY26? A: The LOIs are expected to contribute significantly, with a potential annual revenue addition of INR 1,000 to 1,200 crores once fully ramped up. The company anticipates robust revenue growth as these LOIs are commercialized. (Respondent: Unidentified_6) Q: What is the guidance for standalone top-line growth and margins for FY26? A: The company expects to return to historical growth rates of 25% to 30% plus from FY26 onwards, with margins remaining consistent in the range of 20% to 28%. (Respondent: Unidentified_6) For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
